Bio Techne 주식 가격. TECH - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

71.28

매수가

70.15

매도가

72.42

거래량

620,615

70.61 일간 변동폭 72.4054

61.16 52주 범위 85.57

market_cap

11.326B

전일 종가

71.05

개장가

71.10

최근 거래 시간

112

71.28

(formt)

마지막 거래 시간

재정 규모

US$ 44,295,489

VWAP

71.3735

평균 볼륨(3m)

945,173

발행 주식

158,891,800

배당수익률

0.45%

주가수익률

67.39

주당순이익(EPS)

1.06

매출

1.16B

순이익

168.11M

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.bio-techne.com

본부

Minneapolis, Minnesota, USA

설립됨

Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker TECH. The last closing price for Bio Techne was US$71.05. Over the last year, Bio Techne shares have traded in a share price range of US$ 61.16 to US$ 85.57.

Bio Techne currently has 158,891,800 shares in issue. The market capitalisation of Bio Techne is US$11.29 billion. Bio Techne has a price to earnings ratio (PE ratio) of 67.39.

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES PR Newswire MINNEAPOLIS, Nov. 20, 2024 MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO PR Newswire MINNEAPOLIS, Nov. 14, 2024 Customers will present data from their use of...

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class...

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class C...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, Nov. 8, 2024 MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will...

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy PR Newswire ST. PAUL, Minn., Nov. 7...

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING PR Newswire MINNEAPOLIS, Nov. 6, 2024 MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation...

Form 4 - Statement of changes in beneficial ownership of securities

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.99	-1.3698630137	72.27	72.465	65.61	1746640	67.93144232	CS
4	2.43	3.52941176471	68.85	80.8	65.61	1229005	71.99696412	CS
12	-3.49	-4.66764745219	74.77	80.9499	65.61	945173	73.29249529	CS
26	-9.69	-11.9673953316	80.97	83.96	65.61	932949	74.54732638	CS
52	7.07	11.0107459897	64.21	85.57	61.16	1019953	72.85768062	CS
156	-54.7875	-43.4588613243	126.0675	130.74	51.79	753014	76.45488126	CS
260	17.2875	32.01833588	53.9925	135.9625	38.7925	537502	78.04223436	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	103.6M